NCT07416188 2026-04-16
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
Phase 1/2 Not yet recruiting
Clinical Trials
48 trialsNCT07468136 2026-04-13
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Mayo Clinic
Phase 1/2 Not yet recruiting
NCT07521657 2026-04-13
NF118
University of Alabama at Birmingham
Phase 2 Not yet recruiting
NCT07206849 2026-04-08
Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)
Nationwide Children's Hospital
Phase 2 Not yet recruiting
NCT07089758 2026-03-23
A Study for Cerebral Open Flow Microperfusion
Mayo Clinic
Phase NA Not yet recruiting
NCT07488780 2026-03-23
Language Network Prehab Via fMRI Neurofeedback
Yale University
Phase NA Not yet recruiting
NCT07464925 2026-03-20
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
Tetragon Biosciences Ltd
Phase 1 Not yet recruiting
NCT07481721 2026-03-19
APIC-RG
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1 Not yet recruiting
NCT07472790 2026-03-16
A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1 Not yet recruiting
NCT07469735 2026-03-13
VANGUARD
Huashan Hospital
Phase NA Not yet recruiting
NCT07471100 2026-03-13
Neuromodulation-Induced Cortical Prehabilitation in High Grade Glioma Near the Motor Pathway: Cortical Plasticity Assessed by Navigated Transcranial Magnetic Stimulation (nTMS)
Azienda Sanitaria dell'Alto Adige
Phase NA Not yet recruiting
NCT07465796 2026-03-12
CIPHER
Coherence Neuro Australia Pty Limited
Phase NA Not yet recruiting
NCT07462507 2026-03-10
Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
Washington University School of Medicine
Phase 2 Not yet recruiting
NCT07457307 2026-03-09
INSIGHT MRL
NYU Langone Health
Phase 1 Not yet recruiting
NCT07455045 2026-03-06
A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT07210632 2026-02-27
Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT07438860 2026-02-27
Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG
Case Comprehensive Cancer Center
Phase 1 Not yet recruiting
NCT07439172 2026-02-27
PRC
The Cooper Health System
Phase 2 Not yet recruiting
NCT07439302 2026-02-27
NEURO-PRO-GLIO
Assistance Publique - Hôpitaux de Paris
Phase NA Not yet recruiting
NCT07440290 2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3 Not yet recruiting
NCT07076498 2026-02-25
Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
M.D. Anderson Cancer Center
Phase 1 Not yet recruiting
NCT05676489 2026-02-20
MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors
University of Alabama at Birmingham
Phase EARLY_PHASE1 Not yet recruiting
NCT07424092 2026-02-20
PED-DNX2401
Clinica Universidad de Navarra, Universidad de Navarra
Phase 2 Not yet recruiting
NCT07218367 2026-02-13
Phase I Trial of pH Resections of GBM at VA
VA Office of Research and Development
Phase 1 Not yet recruiting
NCT07389278 2026-02-05
Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)
University of California, San Francisco
Phase 1/2 Not yet recruiting
NCT07376304 2026-01-29
BrainUS-AI
Hospital del Rio Hortega
Phase 3 Not yet recruiting
NCT06357377 2026-01-14
A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
Neonc Technologies, Inc.
Phase 1 Not yet recruiting
NCT04745156 2026-01-12
A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade Gliomas
Medical College of Wisconsin
Phase NA Not yet recruiting
NCT07331064 2026-01-09
GABRIEL
Medical College of Wisconsin
Phase 1 Not yet recruiting
NCT06575452 2025-12-03
EPIGLIO
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Not yet recruiting
NCT07243340 2025-11-21
A Phase I/IIa Study of C5252 in Patients With Intracranial Tumor
ImmVira Pharma Co. Ltd
Phase 1/2 Not yet recruiting
NCT07219199 2025-10-21
Residual IDH1-Mutant Tumor Cell Quantification Study
NYU Langone Health
Phase NA Not yet recruiting
NCT06804655 2025-10-02
EViDENCE-BT
University of Zurich
Phase 2 Not yet recruiting
NCT07021573 2025-09-09
PRIMER
Medical University Innsbruck
Phase NA Not yet recruiting
NCT07120984 2025-08-13
IMAGLIO
Philogen S.p.A.
Phase 2 Not yet recruiting
NCT06617208 2025-08-08
PIONEER
Erasmus Medical Center
Phase NA Not yet recruiting
NCT06750458 2025-04-22
Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients
Tanta University
Phase 3 Not yet recruiting
NCT06914427 2025-04-06
PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique
Xijing Hospital
Phase NA Not yet recruiting
NCT06678867 2025-03-27
P5A
University College, London
Phase 2 Not yet recruiting
NCT06408428 2025-03-12
MicroECoGG
Institut National de la Santé Et de la Recherche Médicale, France
Phase NA Not yet recruiting
NCT06737146 2024-12-17
Study of MT027 in Patients with Recurrent or Progressive High-grade Glioma
Suzhou Maximum Bio-tech Co., Ltd.
Phase 1 Not yet recruiting
NCT06258018 2024-08-30
ONC-2022-001
Istituto Clinico Humanitas
Phase 1/2 Not yet recruiting
NCT06396481 2024-05-02
CSAγδTBMG
Beijing Tiantan Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT06368934 2024-04-16
Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma
Huashan Hospital
Phase NA Not yet recruiting
NCT03763396 2024-03-08
Azoles Targeting Recurrent High Grade Gliomas
University Health Network, Toronto
Phase EARLY_PHASE1 Not yet recruiting
NCT05263466 2022-06-10
Establishing Radiolabelled PSMA as a Target for Glioma Treatment
King's College Hospital NHS Trust
Phase NA Not yet recruiting
NCT05366062 2022-05-13
ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab
Epitopoietic Research Corporation
Phase 2 Not yet recruiting
NCT05140785 2022-03-09
Mapping Molecular Markers of Brain Tumour Activity Using MRI
King's College Hospital NHS Trust
Phase NA Not yet recruiting